文献
J-GLOBAL ID:201702224880246830
整理番号:17A1511498
メチシリン耐性黄色ブドウ球菌(MRSA)感染症の治療の将来の傾向:永続的な病原体に対して活性な新規抗生物質の詳細なレビュー【Powered by NICT】
Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen
著者 (8件):
Bal A.M.
(Department of Microbiology, University Hospital Crosshouse, Kilmarnock KA2 0BE, UK)
,
David M.Z.
(Departments of Medicine, Paediatrics, and Public Health Sciences, University of Chicago, Chicago, IL 60637, USA)
,
Garau J.
(Department of Medicine, Hospital Universitari Mutua de Terrassa, Plaza Dr Robert 5, Barcelona 08221, Spain)
,
Gottlieb T.
(Department of Microbiology and Infectious Diseases, Concord Hospital, Sydney, NSW 2139, Australia)
,
Mazzei T.
(Department of Health Sciences, Clinical Pharmacology and Oncology Section, University of Firenze, Firenze, Italy)
,
Scaglione F.
(Department of Oncology and Onco-Haematology, University of Milan, Via Vanvitelli 32, 20129 Milan, Italy)
,
Tattevin P.
(Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, 35033 Rennes, France)
,
Gould I.M.
(Department of Microbiology, Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK)
資料名:
Journal of Global Antimicrobial Resistance
(Journal of Global Antimicrobial Resistance)
巻:
10
ページ:
295-303
発行年:
2017年
JST資料番号:
W3403A
ISSN:
2213-7165
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)